| Website | creathor.de |
| Phone | +49 6172 - 13 97 20 |
| businessplan@crea... | |
| Employees | 14 |
| Founded | 2003 |
| Description | 25 years of successful venture capital |
| Fund III, 9/11 | €51M |
CREATHOR VENTURE is an independent fund company with no ties to other financial or industry institutions. Currently, the company has 150 million Euro under management and invests in technology-oriented companies and entrepreneurs from the area of IT, telecommunication, media, new materials, nanotechnology, clean tech and life science.
The management team at CREATHOR VENTURE includes the founder of former Technologieholding, Dr. Gert Koehler as well as Ingo Franz and Karlheinz Schmelig. Examples of successful companies the partners have managed from the first round of financing to IPO are Micronas (SMI), SEZ (SMI), Intershop (Prime Segment), Infovista (NASDAQ, Nouveau Marché), POET (Prime Segment, NASDAQ), Wavelight (Prime Segment), Epigenomics (Prime Segment) and ItN Nanovation (Prime Segment).
With 25 years of experience in the venture capital market, CREATHOR VENTURE has been acting as lead investor for more than 200 companies, participating in over 20 IPOs and numerous trade sales. As a result, they provide not only capital but also industry knowledge, expertise at building companies, and the network to develop a sustainable business model with a globally competitive advantage.
Investors of the current fund Creathor Venture III include the European Union’s â€Competitiveness and Innovation Framework Programme“ (â€CIP“), fund-of-funds, family offices, entrepreneurs as well as Creathor’s team.
| Company | Date | Round | Size | Participants |
| Bitbar | 4/13 | Venture Round | $3M | 4 |
| Iconicfuture | 1/13 | Series B | $3.3M | 1 |
| Mobiles Republic | 3/12 | Series A | $3M | 2 |
| cloudControl | 9/11 | Series A | 2 | |
| Sividon Diagnostics | 9/11 | Venture Round | 3 | |
| ShopShare | 8/11 | Venture Round | 1 | |
| CEVEC Pharmaceuticals | 7/11 | Venture Round | €6M | 2 |
| SIRION BIOTECH | 6/11 | Venture Round | 4 | |
| Netbiscuits | 1/11 | Series B | 2 | |
| Zimory | 10/10 | Venture Round | €4M | 2 |
| Phenex Pharmaceuticals | 9/10 | Series C | €6M | 5 |
| Caprotec Bioanalytics | 5/10 | Series B | $5.1M | 4 |
| CEVEC Pharmaceuticals | 2/10 | Series B | $5.4M | 3 |
| joiz | 1/10 | Series A | 1 | |
| aka-aki networks | 10/09 | Venture Round | 2 | |
| Mobiles Republic | 2/09 | Venture Round | 1 | |
| Caprotec Bioanalytics | 1/08 | Venture Round | $8.8M | 3 |
| Doodle | 1/08 | Series A | 2 | |
| Netbiscuits | 1/06 | Series A | 1 |
